Misoprostol for diagnostic curettage in postmenopausal Clinical Observation.doc

Misoprostol for diagnostic curettage in postmenopausal Clinical Observation.doc

  1. 1、本文档共6页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Misoprostol for diagnostic curettage in postmenopausal Clinical Observation

 PAGE \* MERGEFORMAT 6 Misoprostol for diagnostic curettage in postmenopausal Clinical Observation [Abstract] Objective To study in postmenopausal women by diagnostic curettage of cervical vaginal misoprostol before the expansion of the role, in order to reduce the complications of diagnostic curettage. Methods postmenopausal required by diagnostic curettage of 120 cases of women randomly divided into two groups, the observation group 60 cases, diagnostic curettage in 1 ~ 2 h before vaginal misoprostol powder 400 μg, intraoperative ease of cervical dilatation and complications in the control group of 60 patients preoperative use of cervical ripening agents. Results misoprostol group There were no cases of resistance to expanding the number of house not used misoprostol group were more than, less complications. Conclusion 1 ~ 2 h before surgery vaginal misoprostol powder 400 μg, the texture of the cervix, cervical length and cervical position has obvious effect on cervical softening and expansion has a good effect, improve the quality of operation, reducing the complications. [Keywords:] misoprostol, postmenopausal women, diagnostic curettage Postmenopausal women by diagnostic curettage of cervical vaginal misoprostol before the expansion of the role, in order to reduce the complications of diagnostic curettage. Will be required after menopause by diagnostic curettage in 120 patients were randomly divided into two groups of women observed 60 patients, preoperative diagnostic curettage in 1 ~ 2 h powder vaginal misoprostol 400 μg, intraoperative ease of cervical dilatation and complications in the control group, 60 cases of preoperative use of promoting cervical ripening agents. now report clinical data as follows. 1 Materials and Methods 1  1 General information taken from January 2007 to January 2009 in our department who wanted to do diagnostic curettage of 120 cases of postmenopausal women, aged 47 to 69 years old, postmenopausal for 1 to 25 y

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档